Standard Test Method for Lipid Quantitation in Liposomal Formulations Using Ultra-High-Performance Liquid Chromatography (UHPLC) with Triple Quadrupole Mass Spectrometry (TQMS)

SIGNIFICANCE AND USE
5.1 Liposomes are vesicles of nanoscale dimensions, composed of lipid bilayers, which are used for various diagnostic and therapeutic applications (9). The growing interest in liposomal formulations in the delivery of various drugs, antisense oligonucleotides, cloned genes, or recombinant proteins by the biopharmaceutical industry, warrants QC and thorough characterization of the constituent lipids. Lipid structure, composition, and concentration are key attributes in determining the quality and efficacy of a liposomal drug product as they influence the stability of liposomes, drug loading, release kinetics, biodistribution, and pharmacokinetic properties (9). Cholesterol modulates the lipid membrane fluidity, elasticity, and permeability; hence, it plays a key role in controlled drug release and increased stability of the liposome (10).  
5.2 This test method provides a rapid and reliable protocol for the determination of cholesterol, DSPE-PEG 2000, and HSPC in liposomal formulations using UHPLC-TQMS. Assessment of the stability of the analytes in terms of their degradation profiles is not included in this test method (11). This test method will benefit the biopharmaceutical industry in ascertaining quality assessment of liposomal formulations and monitoring batch-to-batch consistency for large-scale production, thereby facilitating safe and efficient drug development and regulatory review.  
5.3 UHPLC-MS/MS measurements are analytically more sensitive and specific for lipid analysis compared to other contemporary techniques using universal detectors, such as a charged aerosol or an evaporative light-scattering detector. For liposomes, MS/MS has further advantages over ultraviolet detectors, as lipids lack chromophores for detection. In this test method, TQMS has been used as the MS/MS technique of choice because of its high selectivity, sensitivity, S/N, accuracy, and broad linear range of quantitation, thereby allowing reproducible quantitation of the analytes,...
SCOPE
1.1 This test method describes the determination of lipid components in liposomal formulations, which includes sample solubilization in methanol followed by separation of the analytes using ultra-high-performance liquid chromatography (UHPLC) and detection with tandem mass-spectrometry (MS/MS). This test method adheres to multiple reaction monitoring (MRM) mass spectrometry on a triple quadrupole mass spectrometer (TQMS).  
1.2 This test method is specific for liposomal formulations containing cholesterol, 1,2- distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol)-2000] (DSPE- PEG 2000), and hydrogenated (soy) L-α-phosphatidylcholine (HSPC).  
1.3 This test method is applicable to report the absolute concentrations of cholesterol, DSPE-PEG 2000, and HSPC and their ratio (DSPE-PEG 2000: HSPC: cholesterol) in liposomal formulations. Assessment of the stability of the analytes in terms of their degradation as a result of oxidation or hydrolysis is beyond the scope of this test method.  
1.4 This test method includes calibration and standardization, sample preparation, UHPLC-TQMS instrumentation, potential interferences, method validation with acceptance criteria, sample analysis, and data reporting.  
1.5 The detection limits for cholesterol, DSPE-PEG 2000, and HSPC using this test method are 5.3, 0.5, and 0.5 ng/g, respectively. In addition, the quantitation limits for cholesterol, DSPE-PEG 2000, and HSPC are 10.6, 0.8, and 0.5 ng/g, respectively.  
1.6 This test method is intended for concentration ranges of 8-1600 ng/g for cholesterol, and of 2-400 ng/g for DSPE-PEG 2000 and HSPC.  
1.7 All observed and calculated values shall conform to the guidelines for significant digits and rounding as established in Practice D6026.  
1.8 Units—The values stated in SI units are to be regarded as the standard. Where appropriate, c.g.s units in addition to SI units are included in this standard.  
1.9 Th...

General Information

Status
Published
Publication Date
14-Jan-2022
Technical Committee
Current Stage
Ref Project

Buy Standard

Standard
ASTM E3324-22 - Standard Test Method for Lipid Quantitation in Liposomal Formulations Using Ultra-High-Performance Liquid Chromatography (UHPLC) with Triple Quadrupole Mass Spectrometry (TQMS)
English language
20 pages
sale 15% off
Preview
sale 15% off
Preview

Standards Content (Sample)

This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the
Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
Designation: E3324 − 22
Standard Test Method for
Lipid Quantitation in Liposomal Formulations Using Ultra-
High-Performance Liquid Chromatography (UHPLC) with
1
Triple Quadrupole Mass Spectrometry (TQMS)
This standard is issued under the fixed designation E3324; the number immediately following the designation indicates the year of
original adoption or, in the case of revision, the year of last revision.Anumber in parentheses indicates the year of last reapproval.A
superscript epsilon (´) indicates an editorial change since the last revision or reapproval.
1. Scope 1.7 All observed and calculated values shall conform to the
guidelines for significant digits and rounding as established in
1.1 This test method describes the determination of lipid
Practice D6026.
components in liposomal formulations, which includes sample
1.8 Units—The values stated in SI units are to be regarded
solubilization in methanol followed by separation of the
asthestandard.Whereappropriate,c.g.sunitsinadditiontoSI
analytes using ultra-high-performance liquid chromatography
units are included in this standard.
(UHPLC) and detection with tandem mass-spectrometry (MS/
MS). This test method adheres to multiple reaction monitoring
1.9 This standard does not purport to address all of the
(MRM) mass spectrometry on a triple quadrupole mass spec-
safety concerns, if any, associated with its use. It is the
trometer (TQMS).
responsibility of the user of this standard to establish appro-
priate safety, health, and environmental practices and deter-
1.2 This test method is specific for liposomal formulations
mine the applicability of regulatory limitations prior to use.
containing cholesterol, 1,2- distearoyl-sn-glycero-3-
1.10 This international standard was developed in accor-
phosphoethanolamine-N-[methoxy (polyethylene glycol)-
dance with internationally recognized principles on standard-
2000] (DSPE- PEG 2000), and hydrogenated (soy) L-α-
ization established in the Decision on Principles for the
phosphatidylcholine (HSPC).
Development of International Standards, Guides and Recom-
1.3 This test method is applicable to report the absolute
mendations issued by the World Trade Organization Technical
concentrationsofcholesterol,DSPE-PEG2000,andHSPCand
Barriers to Trade (TBT) Committee.
their ratio (DSPE-PEG 2000: HSPC: cholesterol) in liposomal
2. Referenced Documents
formulations. Assessment of the stability of the analytes in
2
termsoftheirdegradationasaresultofoxidationorhydrolysis
2.1 ASTM Standards:
is beyond the scope of this test method.
D1193Specification for Reagent Water
D6026Practice for Using Significant Digits and Data Re-
1.4 This test method includes calibration and
cords in Geotechnical Data
standardization, sample preparation, UHPLC-TQMS
D7439Test Method for Determination of Elements in Air-
instrumentation, potential interferences, method validation
borne Particulate Matter by Inductively Coupled Plasma-
with acceptance criteria, sample analysis, and data reporting.
–Mass Spectrometry
1.5 The detection limits for cholesterol, DSPE-PEG 2000,
E177Practice for Use of the Terms Precision and Bias in
and HSPC using this test method are 5.3, 0.5, and 0.5 ng/g,
ASTM Test Methods
respectively.Inaddition,thequantitationlimitsforcholesterol,
E456Terminology Relating to Quality and Statistics
DSPE-PEG 2000, and HSPC are 10.6, 0.8, and 0.5 ng/g,
E682Practice for Liquid Chromatography Terms and Rela-
respectively.
tionships
E2490Guide for Measurement of Particle Size Distribution
1.6 This test method is intended for concentration ranges of
of Nanomaterials in Suspension by Photon Correlation
8-1600 ng/g for cholesterol, and of 2-400 ng/g for DSPE-PEG
Spectroscopy (PCS)
2000 and HSPC.
E3025Guide for TieredApproach to Detection and Charac-
terization of Silver Nanomaterials in Textiles
1
This test method is under the jurisdiction of ASTM Committee E56 on
2
Nanotechnology and is the direct responsibility of Subcommittee E56.08 on For referenced ASTM standards, visit the ASTM website, www.astm.org, or
Nano-Enabled Medical Products. contact ASTM Customer Service at service@astm.org. For Annual Book of ASTM
Current edition approved Jan. 15, 2022. Published April 2022. DOI: 10.1520/ Standards volume information, refer to the standard’s Document Summary page on
E3324-22. the ASTM website.
Copyright © ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959. United States
1

---------------------- Page: 1 ----------------------
E3324 − 22
2.2 Federal Standard: evaporate in the ion source of the mass spectrometer releasing
21 CFR 211.194(a)(2)Code of Federal RegulationsTitle 21, ions to the gas phase for an
...

Questions, Comments and Discussion

Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.